completed

The objective of the RE-LY AF Registry was to evaluate and document the variations in the presentation and management of patients with atrial fibrillation (AF) across various geographies.

Primary endpoints:

1. To determine variations in the predisposing conditions for atrial fibrillation and atrial flutter (AF/flutter) between different regions of the world and practice settings.

2. To document regional variations in the management of AF/flutter and associated cardiovascular disease, including the frequency of anti-thrombotic and anti-hypertensive therapy and the degree of INR control.

3. To document differences in the adverse cardiovascular outcomes of AF/flutter.

Study Type

Observational - Registry

Study Design

Global registry

NO. of Countries

46

NO. of Sites

164

NO. of Participants

15400

Study Period

2007-2009

Sponsor

PHRI

Boehringer Ingelheim

Back To Top